Limited evidence on management of dyslipidemia in HIV

Limited evidence on management of dyslipidemia in HIV

(HealthDay)—A detailed guide has been presented for clinicians who manage dyslipidemia in HIV-infected patients. The guide, based on and extrapolated from guidelines for the general population, has been published online Feb. 4 in the Journal of Clinical Pharmacology.

Merle Myerson, M.D., from Mount Sinai Roosevelt and St. Luke's Hospital in New York City, and colleagues conducted a systematic review to guide clinicians who manage dyslipidemia in patients infected with HIV.

The researchers note that and clinical trials are needed before specific guidelines can be developed to address management of dyslipidemia in this specific patient population. Current guidelines for non-HIV patients should be extrapolated to HIV-infected patients. The investigators present a step-by-step guide for evaluation and management of which includes assessment of cardiovascular risk; establishing targets of therapy; laboratory evaluation; and clinical intervention, including lifestyle changes and medications, with consideration of drug interactions between antiretroviral therapy and lipid-lowering medications.

"The recommendations presented here are based on existing guidelines for the , evidence from research in patients infected with HIV, and the clinical experience of the authors," Myerson and colleagues write. "Management issues for which little or no information is available specific to this patient population are noted and serve to highlight the many gaps in our knowledge that will need to be addressed."

Two authors disclosed financial ties to the pharmaceutical industry.


Explore further

Different approaches needed to control cardiovascular disease risks for those with HIV

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2015 HealthDay. All rights reserved.

Citation: Limited evidence on management of dyslipidemia in HIV (2015, February 15) retrieved 23 October 2019 from https://medicalxpress.com/news/2015-02-limited-evidence-dyslipidemia-hiv.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
31 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more